News & Updates

Show Multimedia Only

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Ovarian hormone suppression gets rid of symptom cyclicity in women with premenstrual dysphoric disorder (PMDD), reports a study. In addition, ovarian steroid addback results in the emergence of symptoms in those with PMDD but not in healthy comparison women.

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Women with gestational diabetes are at heightened risks of overall and specific cardiovascular diseases (CVDs), including chronic hypertension, according to a nationwide population‐based cohort study.

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

25 Oct 2025

Semaglutide is as good as tirzepatide in the treatment of patients with cardiometabolic heart failure with preserved ejection fraction (HFpEF), with both drugs yielding substantial reduction in the risks of cardiac hospitalization and mortality compared with sitagliptin, as reported in a study.

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

25 Oct 2025

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

Semaglutide is a key organ-protective medication for managing cardio-kidney-metabolic (CKM) syndrome. Discover more about positive trial results across seven key components of CKM syndrome, and upcoming data on semaglutide.

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

Mangoes serve up metabolic health benefits for adults with prediabetes

22 Oct 2025 by

Eating mangoes daily may help with glycaemic control, insulin sensitivity, and body composition in adults with prediabetes, as shown in a study.

Mangoes serve up metabolic health benefits for adults with prediabetes

22 Oct 2025

What characterizes patients with PTDM?

22 Oct 2025

Patients with post-transplantation diabetes mellitus (PTDM) tend to be older and have higher BMI, triglyceride levels, and hypertension, according to a study.

What characterizes patients with PTDM?

22 Oct 2025

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

18 Oct 2025 by

Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

18 Oct 2025

Regular fish oil intake tied to lower T2D risk

16 Oct 2025 by

A prospective study evaluating individuals with prediabetes shows an inverse association between habitual fish oil intake and the risk of type 2 diabetes (T2D).

Regular fish oil intake tied to lower T2D risk

16 Oct 2025

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

16 Oct 2025 by

Once-weekly treatment with tirzepatide significantly reduces HbA_1c levels and BMI in children and adolescents with type 2 diabetes (T2D) compared with placebo, according to the SURPASS-PEDS trial presented at EASD 2025.

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

16 Oct 2025

Once-monthly cafraglutide helps with weight loss in adults with obesity

15 Oct 2025

Once-a-month treatment with maridebart cafraglutide—a long-acting peptide–antibody conjugate that combines glucagon-like peptide-1 receptor agonism and glucose-dependent insulinotropic polypeptide receptor antagonism—results in substantial weight reduction in patients with obesity with or without type 2 diabetes, according to a phase II study.

Once-monthly cafraglutide helps with weight loss in adults with obesity

15 Oct 2025

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Ovarian steroid addback increases symptom severity in women with PMDD

Ovarian steroid addback increases symptom severity in women with PMDD

Gestational diabetes tied to increased CVD risks

Gestational diabetes tied to increased CVD risks

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

Semaglutide, tirzepatide equally effective in cardiometabolic HFpEF

[Infographics] Expanding roles of semaglutide in CKM syndrome

[Infographics] Expanding roles of semaglutide in CKM syndrome

Mangoes serve up metabolic health benefits for adults with prediabetes

Mangoes serve up metabolic health benefits for adults with prediabetes

What characterizes patients with PTDM?

What characterizes patients with PTDM?

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

Regular fish oil intake tied to lower T2D risk

Regular fish oil intake tied to lower T2D risk

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

Tirzepatide lowers HbA1c, BMI in youth-onset T2D

Once-monthly cafraglutide helps with weight loss in adults with obesity

Once-monthly cafraglutide helps with weight loss in adults with obesity